OptiNose Historical Financial Ratios
| OPTN Stock | USD 0.50 0.01 1.96% |
OptiNose is promptly reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 0.0 will help investors to properly organize and evaluate OptiNose financial condition quickly.
OptiNose |
About OptiNose Financial Ratios Analysis
OptiNoseFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate OptiNose investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on OptiNose financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across OptiNose history.
OptiNose Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing OptiNose stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on OptiNose sales, a figure that is much harder to manipulate than other OptiNose multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is OptiNose dividend as a percentage of OptiNose stock price. OptiNose dividend yield is a measure of OptiNose stock productivity, which can be interpreted as interest rate earned on an OptiNose investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from OptiNose's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into OptiNose current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.At this time, OptiNose's Payables Turnover is very stable compared to the past year. As of the 11th of December 2024, Income Quality is likely to grow to 0.94, while Price To Sales Ratio is likely to drop 1.93.
| 2023 | 2024 (projected) | Dividend Yield | 0.0518 | 0.0461 | Price To Sales Ratio | 2.04 | 1.93 |
OptiNose fundamentals Correlations
Click cells to compare fundamentals
OptiNose Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OptiNose fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 11.15 | 4.07 | 1.23 | 2.08 | 2.04 | 1.93 | |
| Ptb Ratio | 6.27 | 29.44 | (4.23) | (2.81) | (1.67) | (1.75) | |
| Days Sales Outstanding | 143.79 | 173.85 | 173.32 | 162.37 | 102.46 | 97.33 | |
| Book Value Per Share | 1.47 | 0.14 | (0.38) | (0.66) | (0.77) | (0.73) | |
| Free Cash Flow Yield | (0.38) | (0.24) | (0.43) | (0.84) | (0.14) | (0.15) | |
| Operating Cash Flow Per Share | (2.17) | (1.79) | (1.35) | (0.79) | (0.18) | (0.19) | |
| Stock Based Compensation To Revenue | 0.28 | 0.21 | 0.13 | 0.12 | 0.0732 | 0.0696 | |
| Capex To Depreciation | 0.5 | 0.38 | 0.26 | 0.12 | 0.82 | 0.78 | |
| Pb Ratio | 6.27 | 29.44 | (4.23) | (2.81) | (1.67) | (1.75) | |
| Ev To Sales | 9.05 | 3.68 | 1.5 | 2.57 | 2.85 | 2.71 | |
| Free Cash Flow Per Share | (2.18) | (1.8) | (1.36) | (0.79) | (0.19) | (0.2) | |
| Roic | (0.7) | (0.65) | (0.63) | (0.79) | (0.52) | (0.5) | |
| Inventory Turnover | 1.52 | 0.83 | 0.77 | 0.98 | 1.07 | 0.62 | |
| Net Income Per Share | (2.6) | (2.04) | (1.44) | (0.89) | (0.32) | (0.33) | |
| Days Of Inventory On Hand | 240.21 | 438.87 | 472.53 | 372.09 | 340.44 | 323.41 | |
| Payables Turnover | 1.46 | 1.37 | 1.14 | 1.75 | 2.22 | 2.33 | |
| Research And Ddevelopement To Revenue | 0.6 | 0.48 | 0.34 | 0.2 | 0.0747 | 0.071 | |
| Capex To Revenue | 0.0161 | 0.0111 | 0.002237 | 8.26E-4 | 0.004621 | 0.00439 | |
| Cash Per Share | 3.51 | 2.99 | 1.94 | 1.1 | 0.66 | 0.62 | |
| Pocfratio | (4.25) | (2.32) | (1.2) | (2.35) | (7.04) | (6.69) | |
| Interest Coverage | (9.93) | (6.71) | (4.16) | (3.32) | (1.16) | (1.22) | |
| Capex To Operating Cash Flow | (0.006133) | (0.006334) | (0.002171) | (9.31E-4) | (0.016) | (0.0168) | |
| Pfcf Ratio | (4.23) | (2.3) | (1.19) | (2.35) | (6.93) | (6.58) | |
| Days Payables Outstanding | 249.93 | 266.42 | 319.61 | 208.49 | 164.3 | 156.08 | |
| Roe | (1.77) | (14.49) | 3.75 | 1.35 | 0.41 | 0.43 | |
| Ev To Operating Cash Flow | (3.45) | (2.1) | (1.46) | (2.89) | (9.87) | (9.38) | |
| Pe Ratio | (3.54) | (2.03) | (1.13) | (2.08) | (4.07) | (3.87) | |
| Return On Tangible Assets | (0.49) | (0.63) | (0.52) | (0.53) | (0.33) | (0.35) | |
| Ev To Free Cash Flow | (3.43) | (2.09) | (1.46) | (2.89) | (9.71) | (9.23) | |
| Earnings Yield | (0.28) | (0.49) | (0.89) | (0.48) | (0.25) | (0.26) | |
| Net Debt To E B I T D A | 0.73 | 0.22 | (0.31) | (0.64) | (3.73) | (3.55) | |
| Current Ratio | 4.07 | 2.76 | 2.71 | 0.53 | 0.6 | 0.57 | |
| Tangible Book Value Per Share | 1.47 | 0.14 | (0.38) | (0.66) | (0.77) | (0.73) | |
| Receivables Turnover | 2.54 | 2.1 | 2.11 | 2.25 | 3.56 | 4.83 | |
| Graham Number | 9.28 | 2.54 | 3.52 | 3.63 | 2.35 | 2.23 | |
| Shareholders Equity Per Share | 1.47 | 0.14 | (0.38) | (0.66) | (0.77) | (0.73) | |
| Debt To Equity | 1.21 | 18.44 | (5.81) | (2.27) | (1.5) | (1.43) | |
| Capex Per Share | 0.0133 | 0.0113 | 0.002937 | 7.33E-4 | 0.002926 | 0.00278 | |
| Graham Net Net | 1.15 | (0.33) | (0.79) | (0.89) | (0.91) | (0.86) |
Pair Trading with OptiNose
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OptiNose position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will appreciate offsetting losses from the drop in the long position's value.Moving together with OptiNose Stock
Moving against OptiNose Stock
| 0.82 | BMY | Bristol Myers Squibb | PairCorr |
| 0.68 | CAH | Cardinal Health | PairCorr |
| 0.59 | ESPR | Esperion Therapeutics | PairCorr |
| 0.59 | XAIR | Beyond Air | PairCorr |
| 0.53 | GILD | Gilead Sciences | PairCorr |
The ability to find closely correlated positions to OptiNose could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OptiNose when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OptiNose - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OptiNose to buy it.
The correlation of OptiNose is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OptiNose moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OptiNose moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OptiNose can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share 0.553 | Quarterly Revenue Growth 0.031 | Return On Assets (0.10) | Return On Equity (10.51) |
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.